Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06577025
What this trial is testing

Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 43
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Early research (Phase 1)Study completedNCT02129582
What this trial is testing

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaHematologic MalignanciesAcute Lymphocytic Leukemia+8 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT06976476
What this trial is testing

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Who this might be right for
Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired
Memorial Sloan Kettering Cancer Center 100
Not applicableStudy completedNCT01809717
What this trial is testing

Multiple Myeloma and Exercise

Who this might be right for
Newly Diagnosed Multiple Myeloma
Abramson Cancer Center at Penn Medicine 10
Not applicableActive Not RecruitingNCT04108624
What this trial is testing

Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Chicago 68
Not applicableStudy completedNCT05393024
What this trial is testing

Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 78
Early research (Phase 1)Study completedNCT02426723
What this trial is testing

Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients

Who this might be right for
Multiple Myeloma
JW Pharmaceutical 25
Testing effectiveness (Phase 2)Study completedNCT01057225
What this trial is testing

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Who this might be right for
Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Mayo Clinic 64
Not applicableEnded earlyNCT02394210
What this trial is testing

Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 415
Large-scale testing (Phase 3)Active Not RecruitingNCT05556720
What this trial is testing

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Who this might be right for
HIVOrgan TransplantationLymphoma, Non-Hodgkin+3 more
Monash University 960
Testing effectiveness (Phase 2)Ended earlyNCT01343368
What this trial is testing

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more
Masonic Cancer Center, University of Minnesota 19
Testing effectiveness (Phase 2)Study completedNCT00006350
What this trial is testing

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Not applicableNo Longer AvailableNCT00063791
What this trial is testing

Assess Two Different Strategies of Combining Dexamethasone and VELCADE

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07585760
What this trial is testing

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China 26
Early research (Phase 1)WithdrawnNCT02951117
What this trial is testing

Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Who this might be right for
Multiple Myeloma
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00378768
What this trial is testing

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Study completedNCT00111813
What this trial is testing

Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 34
Testing effectiveness (Phase 2)Looking for participantsNCT07099391
What this trial is testing

Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Ended earlyNCT04816526
What this trial is testing

Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Who this might be right for
Myeloma Multiple
Cartesian Therapeutics 13
Next Page